![](https://cdn-ak-scissors.b.st-hatena.com/image/square/6f719ed9a7497a6ac55a955eb6aabcf37666ab4d/height=288;version=1;width=512/https%3A%2F%2Fichef.bbci.co.uk%2Fnews%2F1024%2Fbranded_news%2F16BEF%2Fproduction%2F_85676139_martinshkreli.jpg)
エントリーの編集
![loading...](https://b.st-hatena.com/bdefb8944296a0957e54cebcfefc25c4dcff9f5f/images/v4/public/common/loading@2x.gif)
エントリーの編集は全ユーザーに共通の機能です。
必ずガイドラインを一読の上ご利用ください。
記事へのコメント1件
- 注目コメント
- 新着コメント
注目コメント算出アルゴリズムの一部にLINEヤフー株式会社の「建設的コメント順位付けモデルAPI」を使用しています
![アプリのスクリーンショット](https://b.st-hatena.com/bdefb8944296a0957e54cebcfefc25c4dcff9f5f/images/v4/public/entry/app-screenshot.png)
- バナー広告なし
- ミュート機能あり
- ダークモード搭載
関連記事
US drug company to cut 5,000% price rise after backlash
Turing Pharmaceuticals boss Martin Shkreli had previously defended the price raise A US drug comp... Turing Pharmaceuticals boss Martin Shkreli had previously defended the price raise A US drug company that faced a backlash after raising the price of a drug used by Aids patients by over 5,000% has said it will lower the price. Martin Shkreli, the head of Turing Pharmaceuticals, told US media he would drop the price following the outcry, but did not say by how much. Turing Pharmaceuticals acquired
2015/09/24 リンク